I ett snabbväxande amerikanskt finansforum hittas en PHI-entusiastisk jänkare.
Snubben är verkligen påläst och har onekligen gjort sin hemläxa ordentligt.Se alla länkar.
Såhär avslutar han sitt långa men välkomponerade inlägg Swedish Biotech :
"The company has been around for almost 20 years and has an enormous
baggage of credibility with doing business with governments,
universities and research labs around the world.
I believe this stock to
be a submarine right now and once it reaches the surface and more
people know about their business idea and position then it will
transform into a rocket and fly up very high in value because of its
fantastic business model and of its low free float of only having 14
million shares. This company is a true gem that should be in any
investors portfolio be it in the long run or short. I think trading
alone can bring this stock to 15$-25$ and who knows how much money they
can be offered if all goes their way."
Inga kommentarer:
Skicka en kommentar